The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Bacterial Resistance: Origins, Epidemiology, and Impact
Abstract
The basic mechanisms of antibacterial resistance are well known, but critical new aspects continue to be discovered. Recently discovered factors with major implications for the emergence, dissemination, and maintenance of resistance include multidrug efflux, hypermutability, integrons, and plasmid addiction. Some resistances are widespread and others local, with prevalence rates often worst in newly prosperous countries and in those specialist units where antibacterial use is heaviest. Multidrug-resistant epidemic strains are critical to the total accumulation of resistance (e.g., among Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, Klebsiella pneumoniae), but it remains unclear why some bacterial lineages achieve epidemic spread whereas others that are equally resistant do not. The correlation between in vitro resistance and treatment failure is imperfect, but resistance undoubtedly increases mortality, morbidity, and costs in many settings. Recent concern has led to a plethora of governmental and agency reports advocating less antibacterial use, better antibacterial use, better infection control, and the development of new antibacterials. The evidence that better prescribing can reduce resistance rates is mixed, and although changes to hospital regimens may reduce one resistance problem, other opportunistic bacteria may fill the vacant niche. Overall, the best that can reasonably be anticipated is an improved balance between the accumulation of resistance and new antibacterial development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. (2005) · doi:10.1128/9781555816704 · Cited by 5,683
Bootsma, D., & Hoeijmakers, J. H. J. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)81408-9 · Cited by 2,282
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Methicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Resistance to Antibiotics Mediated by Target Alterations
Spratt, B. G. (1994) · Science · doi:10.1126/science.8153626 · Cited by 674
Rahal, J. J. (1998) · JAMA · doi:10.1001/jama.280.14.1233 · Cited by 642
Emerging Mechanisms of Fluoroquinolone Resistance
Hooper, D. C. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010239 · Cited by 633
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d30.x · Cited by 620
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Threlfall, E. J. (2002) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00092-x · Cited by 497
The Influence of Mini-BAL Cultures on Patient Outcomes
MD, M. H. K., & Ward, S. (1998) · Chest · doi:10.1378/chest.113.2.412 · Cited by 494
Enne, V. I., Livermore, D. M., Stephens, P., & Hall, L. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04519-0 · Cited by 486
Self-citationAntibiotic resistance in staphylococci
Livermore, D. M. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00299-5 · Cited by 471
Self-citationMultidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 456
Evolution of a bacteria/plasmid association
Bouma, J. E., & Lenski, R. E. (1988) · Nature · doi:10.1038/335351a0 · Cited by 446
Archibald, L., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F., & Gaynes, R. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.211 · Cited by 436
Intercontinental Spread of a Multiresistant Clone of Serotype 23F Streptococcus pneumoniae
Munoz, R., Coffey, T. J., Daniels, M., Dowson, C. G., Laible, G., Casal, J., Hakenbeck, R., Jacobs, M., Musser, J. M., Spratt, B. G., et al. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.2.302 · Cited by 419
Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era
Hughes, V. M., & Datta, N. (1983) · Nature · doi:10.1038/302725a0 · Cited by 406
Li, X. Z., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1732 · Cited by 402
Self-citationSTAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200203000-00016 · Cited by 395
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Barbosa, T. M., & Levy, S. B. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.12.3467-3474.2000 · Cited by 371
Everett, M. J., Jin, Y. F., Ricci, V, & Piddock, L. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365
Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents
Drusano, G. L. (2003) · Clinical Infectious Diseases · doi:10.1086/344653 · Cited by 356
Emergence and Dissemination of Quinolone-Resistant Escherichia coli in the Community
Garau, J., Xercavins, M., Rodríguez-Carballeira, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T., & Ruíz-Bremón, A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2736 · Cited by 337
Willems, R. J., Homan, W., Top, J., van Santen-Verheuvel, M., Tribe, D., Manzioros, X., Gaillard, C., Vandenbroucke-Grauls, C. M., Mascini, E. M., van Kregten, E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04205-7 · Cited by 327
Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria
Courvalin, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1447 · Cited by 327
Carbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
Self-citationMechanisms of Fluoroquinolone Resistance: An Update 1994-1998
Piddock, L. J. V. (1999) · Drugs · doi:10.2165/00003495-199958002-00003 · Cited by 308
Reacher, M. H. (2000) · BMJ · doi:10.1136/bmj.320.7229.213 · Cited by 305
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Prystowsky, J., Siddiqui, F., Chosay, J., Shinabarger, D. L., Millichap, J., Peterson, L. R., & Noskin, G. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2154-2156.2001 · Cited by 302
Wang, H., Dzink-Fox, J. L., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
Antibiotic Treatment for Surgical Peritonitis
MOSDELL, D. M., MORRIS, D. M., VOLTURA, A., PITCHER, D. E., TWIEST, M. W., MILNE, R. L., MISCALL, B. G., & FRY, D. E. (1991) · Annals of Surgery · doi:10.1097/00000658-199111000-00001 · Cited by 280
Song, J., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C., Lalitha, M. K., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514783 · Cited by 258
Johnson, A. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.143 · Cited by 247
Vahaboglu, H., Oztürk, R., Aygün, G., Coşkunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K., & Otkun, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2265 · Cited by 236
Oethinger, M., Kern, W. V., Jellen-Ritter, A. S., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa
Nordmann, P., Ronco, E., Naas, T., Duport, C., Michel-Briand, Y., & Labia, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.962 · Cited by 201
Austin, D. J., & Anderson, R. M. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0425 · Cited by 195
Rebeck, G. W., & Samson, L. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.6.2068-2076.1991 · Cited by 188
Mobile Gene Cassettes and Integrons: Moving Antibiotic Resistance Genes in Gram‐Negative Bacteria
Hall, R. M. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470515358.ch12 · Cited by 169
Urban, C., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
Pneumococcal Resistance to β-Lactam Antibiotics: A Global Geographic Overview
Baquero, F. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.115 · Cited by 159
Marshall, C. G., Broadhead, G., Leskiw, B. K., & Wright, G. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6480 · Cited by 146
Bradley, S. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.261 · Cited by 143
Glycopeptide-resistant enterococci: a decade of experience
Woodford, N. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-10-849 · Cited by 142
Ysern, P., Clerch, B., Castańo, M., Gibert, I., Barbé, J., & Llagostera, M. (1990) · Mutagenesis · doi:10.1093/mutage/5.1.63 · Cited by 140
Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli
Kern, W. V., Oethinger, M. D., Jellen-Ritter, A., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.814-820.2000 · Cited by 140
Essack, S. Y., Hall, L. M. C., Pillay, D. G., McFadyen, M. L., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.88-95.2001 · Cited by 133
Self-citationIn search of natural substrates and inhibitors of MDR pumps.
Lewis, K. (2001) · PubMed · Cited by 126
Oliver, A., Pérez-Díaz, J. C., Coque, T. M., Baquero, F., & Cantón, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.616-620.2001 · Cited by 120
Enterococci and Vancomycin Resistance
French, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/514910 · Cited by 110
Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone
Bosi, C., Davin‐Regli, A., Bornet, C., Malléa, M., Pagès, J., & Claude Bollet, C. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2165-2169.1999 · Cited by 101
Macrolide‐ResistantStreptococcus pneumoniaeand Use of Antimicrobial Agents
Pihlajamäki, M., Kotilainen, P., Kaurila, T., Klaukka, T., Palva, E., Huovinen, P., & the Finnish Study Group for Antimicrobial Resistance (FiRe‐Network) (2001) · Clinical Infectious Diseases · doi:10.1086/322735 · Cited by 94
Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa
Danel, F., Hall, L. M. C., Gür, D., Akalın, H., & Livermore, D. M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.281 · Cited by 91
Self-citationQuinupristin/dalfopristin and linezolid: where, when, which and whether to use?
Livermore, D. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.347 · Cited by 89
Self-citationCasin, I., Breuil, J., Brisabois, A., Moury, F., Grimont, F., & Collatz, E. (1999) · The Journal of Infectious Diseases · doi:10.1086/314733 · Cited by 88
Chiew, Y.-F. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.2.247 · Cited by 86
The Cost of Antibiotic Resistance—from the Perspective of a Bacterium
Lenski, R. E. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515358.ch9 · Cited by 85
Chang, C., Chang, Y., CHANG, L.-L., Chang, S., & Lee, T.-M. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-12-1097 · Cited by 83
Martino, P. D., Livrelli, V., Sirot, D., Joly, B., & Darfeuille–Michaud, A. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2266-2273.1996 · Cited by 71
Hypermutation in bacteria and other cellular systems
Bridges, B. A. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0745 · Cited by 71
Epidemiology of Penicillin Resistant Pneumococci in Iceland
Kristinsson, K. G. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.121 · Cited by 67
Origin, evolution and dissemination of antibiotic resistance genes.
Trieu‐Cuot, P., Arthur, M., & Courvalin, P. M. (1987) · PubMed · Cited by 60
Rawlings, D. E. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13672.x · Cited by 51
Antibiotic Cycling: Is It Ready for Prime Time?
John, J. F. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501689 · Cited by 39
King, J. W., White, M. C., Todd, J. R., & Conrad, S. A. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.4.908 · Cited by 30
MARTON, A., & Mészner, Z. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.201 · Cited by 18
Cited by
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H., & Pringle, M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-13 · Cited by 1,262
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Metadata
- Authors
- Livermore, D. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-15
- Volume
- 36
- Issue
- Supplement_1
- Pages
- S11-S23
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2167275970
- Cited by
- 586
- References
- 76
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.